Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?
Journal of Drugs in Dermatology: JDD, 2012 - europepmc.org
We propose rituximab as a first-line therapy for pemphigus vulgaris and steroid-dependent
bullous pemphigoid with or without systemic steroids. A brief review of the literature …
bullous pemphigoid with or without systemic steroids. A brief review of the literature …
Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?
R Nigam, J Levitt - Journal of drugs in dermatology: JDD, 2012 - pubmed.ncbi.nlm.nih.gov
We propose rituximab as a first-line therapy for pemphigus vulgaris and steroid-dependent
bullous pemphigoid with or without systemic steroids. A brief review of the literature …
bullous pemphigoid with or without systemic steroids. A brief review of the literature …